B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
Michael Levy,1 Maureen A Mealy2 1Department of Neurology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA; 2Medical Affairs, Horizon Therapeutics, Deerfield, IL, USACorrespondence: Michael LevyMassachusetts General Hospital & Harvard Medical School, 55 Fruit Street,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2021-08-01
|
| Series: | ImmunoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/b-cell-targeted-treatments-for-neuromyelitis-optica-spectrum-disorder--peer-reviewed-fulltext-article-ITT |